| |
Newsroom /
Health and Fitness
/
Health and Fitness
/
EMR Releases a New Series of Reports on Key Hormonal Contraceptive Drug Markets
EMR Releases a New Series of Reports on Key Hormonal Contraceptive Drug Markets
EMR’s latest publications provide an exceptional tool to understand the current trends, therapeutic structure, competitive landscape and the outlook for key hormonal contraceptive drug markets till 2016.
Noida,
UP,
India
(prbd.net)
21/09/2011
In its new series of reports on hormonal contraceptives, Expert Market Research, one of the world’s leading providers of lifescience market intelligence, analyses the market potential of hormonal contraceptive drugs in key developed and emerging markets.
EMR’s hormonal contraceptive market series includes reports on the following countries:
• US Hormonal Contraceptive Market Report and Forecast: 2011-2016
• Germany Hormonal Contraceptive Market Report and Forecast: 2011-2016
• Brazil Hormonal Contraceptive Market Report and Forecast: 2011-2016
• France Hormonal Contraceptive Market Report and Forecast: 2011-2016
• Spain Hormonal Contraceptive Market Report and Forecast: 2011-2016
• Italy Hormonal Contraceptive Market Report and Forecast: 2011-2016
• Canada Hormonal Contraceptive Market Report and Forecast: 2011-2016
• UK Hormonal Contraceptive Market Report and Forecast: 2011-2016
• Mexico Hormonal Contraceptive Market Report and Forecast: 2011-2016
• Russia Hormonal Contraceptive Market Report and Forecast: 2011-2016
• Argentina Hormonal Contraceptive Market Report and Forecast: 2011-2016
• Australia Hormonal Contraceptive Market Report and Forecast: 2011-2016
• Japan Hormonal Contraceptive Market Report and Forecast: 2011-2016
• Thailand Hormonal Contraceptive Market Report and Forecast: 2011-2016
Each of these reports provide a comprehensive analysis on the current and future market trends in the hormonal contraceptive drugs market. These reports facilitate a deep insight into the total sales, performance of various therapeutic classes, companies, molecules and brands. These reports can serve as an excellent guide for clients who are in need of an in-depth understanding of the market for hormonal contraceptive drugs.
Key Questions Answered in these Reports:
• What has been the historical performance of the hormonal contraceptive market and how will it behave in the coming years?
• What has been the historical performance of various hormonal contraceptive therapeutic classes?
• Who are the leading companies in the hormonal contraceptive market?
• Which are the leading drugs in the hormonal contraceptive market?
• What is the product portfolio of key players in the hormonal contraceptive market?
Why should you buy these Reports?
• To facilitate business decision-making based on historical, current and future market data for hormonal contraceptives.
• To identify potential classes, drugs, partners and competitors so as to develop strategies for market penetration and drug development.
• To develop business strategies by looking at companies that have been the biggest winners and losers in the hormonal contraceptive market.
• To gain an understanding into future market events and make more informed business decisions.
Research Objectives Achieved in these Reports:
Comprehensive Situation Analysis of the Hormonal Contraceptive Markets:
Classes Covered: Monophasic Preparations (less than 50 mcg oestrogen), Monophasic Preparations (equal or more than 50 mcg oestrogen), Biphasic Preparations, Triphasic Preparations, Progestogen-Only preparations (oral) and All Other Hormonal Contraceptives.
Key Aspects Analyzed:
• Historical, current and future market trends
• Market performance of various therapeutic classes
• Market performance of various companies
• Market performance of various drugs
• Product portfolio of various companies
• Market Forecasts
Methodology & Information Sources:
To prepare this report, material was mined from both primary and secondary data sources. Primary information sources included data provided by pharmaceutical manufacturers, marketing strategists, scientists, doctors and product managers at leading pharmaceutical companies. Secondary data sources include both proprietary and public databases. These included company websites, annual reports, financial reports, 10K’s, government resources, books, magazines, white papers, journals, analyst reports and access to thousands of proprietary databases.
Table of Contents
1. Research Methodology & Definitions
2. Executive Summary
3. The Hormonal Contraceptive Drugs Market Landscape
3.1 Current Trends & Forecast
3.1.1 Current Market Trends
3.1.2 Sales of Various Companies
3.1.3 Market Forecast
3.2 Performance of Various Therapeutic Classes
3.2.1 Monophasic Preparations (Less Than 50 mcg Oestrogen),
3.2.1.1 Current Market Trends
3.2.1.2 Sales of Key Companies
3.2.1.3 Drug Portfolio of Key Companies
3.2.1.4 Sales Forecast
3.2.2 Monophasic Preparations (Equal Or More Than 50 mcg Oestrogen)
3.2.2.1 Current Market Trends
3.2.2.2 Sales of Key Companies
3.2.2.3 Drug Portfolio of Key Companies
3.2.2.4 Sales Forecast
3.2.3 Biphasic Preparations
3.2.3.1 Current Market Trends
3.2.3.2 Sales of Key Companies
3.2.3.3 Drug Portfolio of Key Companies
3.2.3.4 Sales Forecast
3.2.4 Triphasic Preparations
3.2.4.1 Current Market Trends
3.2.4.2 Sales of Key Companies
3.2.4.3 Drug Portfolio of Key Companies
3.2.4.4 Sales Forecast
3.2.5 Progestogen-Only Preparations (Oral)
3.2.5.1 Current Market Trends
3.2.5.2 Sales of Key Companies
3.2.5.3 Drug Portfolio of Key Companies
3.2.5.4 Sales Forecast
3.2.6 All Other Hormonal Contraceptives
3.2.6.1 Current Market Trends
3.2.6.2 Sales of Key Companies
3.2.6.3 Drug Portfolio of Key Companies
3.2.6.4 Sales Forecast
To buy the complete report or to get a free sample:
Call: +91-880-236-2536 (Asia), +1 206 204-1851 (America & Europe)
Email: sales@expertmarketresearch.com
To know more please visit: http://www.expertmarketresearch.com
About
Expert Market Research is one of the world’s leading providers of lifescience market intelligence. Our award winning and trusted portfolio of proprietary business solutions have been supporting some of the world’s leading pharmaceutical companies, biotechnology companies, medical device companies, clinical research organizations, contract manufacturers and hospitals for over 6 years. We have helped organizations in achieving peak performance, maintaining their leadership positions and raising th
|